Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-3_14-cv-04265/USCOURTS-cand-3_14-cv-04265-5/pdf.json

Nature of Suit Code: 791
Nature of Suit: Employee Retirement Income Security Act (ERISA)
Cause of Action: 29:1132 E.R.I.S.A.: Employee Benefits

---

STIPULATION RE CONTINUING

MEDIATION COMPLETION DATE

3:14-CV-04265-MMC

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

MORGAN, LEWIS &

BOCKIUS LLP

ATTORNEYS AT LAW

SAN FRANCISCO

MORGAN, LEWIS & BOCKIUS LLP

Nicole A. Diller, State Bar No. 154842

ndiller@morganlewis.com

Roberta H. Vespremi, State Bar No. 225067

rvespremi@morganlewis.com

One Market, Spear Street Tower

San Francisco, California 94105-1126

Tel: +1.415.442.1000

Fax: +1.415.442.1001

Attorneys for Defendants

GENENTECH-ROCHE PHARMA TRANSITIONAL

BENEFITS PLAN (erroneously sued as GenentechRoche Transitional Benefit Plan); GENENTECH,

INC.; and PLAN ADMINISTRATOR OF THE

GENENTECH-ROCHE PHARMA TRANSITIONAL

BENEFITS PLAN (erroneously sued as Genentech

Plan Administrator and Genentech Plan Fiduciary)

UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF CALIFORNIA

MICHAEL DEL AGUILA,

Plaintiff,

vs.

GENENTECH-ROCHE TRANSITIONAL

BENEFIT PLAN, an unknown entity;

GENENTECH, INC.; GENENTECH PLAN

ADMINISTRATOR; GENENTECH PLAN

FIDUCIARY; and DOES 1-50,

Defendants.

Case No. 3:14-cv-04265-MMC

STIPULATION AND [PROPOSED]

ORDER TO CONTINUE MEDIATION

COMPLETION DATE

[Civil Local Rules 6-1, 6-2]

Case 3:14-cv-04265-MMC Document 32 Filed 03/10/15 Page 1 of 4
1

STIPULATION RE CONTINUING

MEDIATION COMPLETION DATE

3:14-CV-04265-MMC

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

MORGAN, LEWIS &

BOCKIUS LLP

ATTORNEYS AT LAW

SAN FRANCISCO

Pursuant to Civil Local Rules 6-1(b) and 6-2, Plaintiff Michael del Aguila and Defendants

Genentech-Roche Pharma Transitional Benefits Plan (erroneously sued as Genentech-Roche

Transitional Benefit Plan); Genentech, Inc.; and Plan Administrator of the Genentech-Roche

Pharma Transitional Benefits Plan (erroneously sued as Genentech Plan Administrator and

Genentech Plan Fiduciary) (collectively, the “Parties”), by and through their respective counsel of

record, stipulate to continue the mediation completion date.

WHEREAS, at the Initial Case Management Conference held on January 30, 2015, the

Court ordered that the Parties complete court-sponsored mediation within 90 days (April 30,

2015) (Dkt. No. 27);

WHEREAS, on February 26, 2015, the Parties discussed settlement considerations and

determined that they need some discovery and resolution of a motion in order to potentially

bridge substantially differing views on the merits of the case;

WHEREAS, the Parties agree that an additional 60 days to complete mediation, to June

29, 2015, may benefit the settlement process by allowing such discovery and motion work to

inform the Parties’ respective views of the case;

WHEREAS, the Parties have requested one continuance in this matter previously to

continue the Initial Case Management Conference (Dkt. No. 22), which the Court granted (Dkt.

No. 23);

WHEREAS, the Parties do not request an extension of any other date set in this matter,

therefore a continuance will not affect the remaining schedule case or prejudice the Parties.

///

///

///

///

///

///

///

///

Case 3:14-cv-04265-MMC Document 32 Filed 03/10/15 Page 2 of 4
2

STIPULATION RE CONTINUING

MEDIATION COMPLETION DATE

3:14-CV-04265-MMC

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

MORGAN, LEWIS &

BOCKIUS LLP

ATTORNEYS AT LAW

SAN FRANCISCO

THEREFORE, IT IS STIPULATED by the Parties and respectfully requested that the

mediation completion date currently set for April 30, 2015 be continued 60 days to June 29, 2015.

IT IS SO STIPULATED.

Dated: March 9, 2015 MORGAN, LEWIS & BOCKIUS LLP

By /s/ Nicole A. Diller

Nicole A. Diller

Attorneys for Defendants

GENENTECH-ROCHE PHARMA TRANSITIONAL

BENEFITS PLAN (erroneously sued as GenentechRoche Transitional Benefit Plan); GENENTECH, INC.;

and PLAN ADMINISTRATOR OF THE

GENENTECH-ROCHE PHARMA TRANSITIONAL

BENEFITS PLAN (erroneously sued as Genentech Plan

Administrator and Genentech Plan Fiduciary)

Dated: March 9, 2015 TOD M. RATFIELD, APC

By /s/ Tod M. Ratfield

Tod M. Ratfield

Attorneys for Plaintiff

MICHAEL DEL AGUILA

FILER’S ATTESTATION

I, Nicole A. Diller, am the ECF user whose identification and password are being used to

file this Stipulation and [Proposed] Order to Continue the Mediation Completion Date. In

compliance with L.R. 5-1(i)(3), I hereby attest that Tod M. Ratfield concurs in this filing.

Dated: March 9, 2015 /s/ Nicole A. Diller

Nicole A. Diller

///

///

///

///

Case 3:14-cv-04265-MMC Document 32 Filed 03/10/15 Page 3 of 4
3

STIPULATION RE CONTINUING

MEDIATION COMPLETION DATE

3:14-CV-04265-MMC

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

MORGAN, LEWIS &

BOCKIUS LLP

ATTORNEYS AT LAW

SAN FRANCISCO

DB2/ 25776120.1

[PROPOSED] ORDER

Pursuant to the Parties’ Stipulation to Continue the Mediation Completion Date and for

good cause appearing, the Stipulation is approved. The Court orders as follows:

The mediation completion date currently set for April 30, 2015 is continued 60 days to

June 29, 2015.

IT IS SO ORDERED.

Dated: ___________________ ______________________________

HON. MAXINE M. CHESNEY

UNITED STATES DISTRICT JUDGE

March 10, 2015

Case 3:14-cv-04265-MMC Document 32 Filed 03/10/15 Page 4 of 4